Glucose-dependent Insulinotropic Polypeptide Receptor Agonist
12 drugs across 1 manufacturer|0 Generic,12 Brand
The Glucose-dependent Insulinotropic Polypeptide Receptor Agonist class contains 12 NDCs from 1 manufacturer (0 generic, 12 brand), at an average NADAC of $532.32 per unit. Every drug, manufacturer, and price in this FDA-defined pharmacologic class is listed below.
Total Drugs
12
0G / 12B
Manufacturers
1
Avg $532.3197/unit
Avg 7d Change
+0.03%
Across 12 drugs with changes
7d Activity
of 12 total drugs
Class Price Trend
Monthly average NADAC price per unit, split by generic and brand
Manufacturer Breakdown
1 manufacturer producing drugs in this therapeutic class
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
MOUNJARO 2.5 MG/0.5 ML PEN tirzepatide | $538.6884 per ML | +0.01% |
MOUNJARO 10 MG/0.5 ML PEN tirzepatide | $538.6836 per ML | +0.01% |
MOUNJARO 7.5 MG/0.5 ML PEN tirzepatide | $538.6804 per ML | +0.01% |
MOUNJARO 5 MG/0.5 ML PEN tirzepatide | $538.6338 per ML | +0.01% |
MOUNJARO 12.5 MG/0.5 ML PEN tirzepatide | $538.5252 per ML | +0.01% |
MOUNJARO 15 MG/0.5 ML PEN tirzepatide | $538.5176 per ML | +0.01% |
ZEPBOUND 2.5 MG/0.5 ML PEN tirzepatide | $526.2042 per ML | +0.02% |
ZEPBOUND 5 MG/0.5 ML PEN tirzepatide | $526.0828 per ML | +0.01% |
ZEPBOUND 10 MG/0.5 ML PEN tirzepatide | $526.0461 per ML | +0.05% |
ZEPBOUND 7.5 MG/0.5 ML PEN tirzepatide | $526.0041 per ML | +0.04% |
ZEPBOUND 15 MG/0.5 ML PEN tirzepatide | $525.9221 per ML | +0.04% |
ZEPBOUND 12.5 MG/0.5 ML PEN tirzepatide | $525.8487 per ML | +0.01% |
Follow this class across the site
These links connect the therapeutic class page to the specific suppliers, markets, and trend surfaces that help users keep exploring.
Top supplier
Eli Lilly and Company manufacturer profile
Review the supplier with the strongest product footprint inside this therapeutic class.
Lead market
tirzepatide market page
Move from the therapeutic class into the molecule that appears most often in this class-specific portfolio.
Trend hub
Latest trend hub
Compare this class against the rest of the weekly NADAC trend surface.
Guide
Understanding NADAC pricing
Use the explainer when you need a plain-English refresher on how these class-level numbers are published and interpreted.
Frequently Asked Questions
How many drugs are in the Glucose-dependent Insulinotropic Polypeptide Receptor Agonist class?
The Glucose-dependent Insulinotropic Polypeptide Receptor Agonist class contains 12 NDCs from 1 manufacturer — 0 generic and 12 brand products.
What is the average price of Glucose-dependent Insulinotropic Polypeptide Receptor Agonist drugs?
The average NADAC for the Glucose-dependent Insulinotropic Polypeptide Receptor Agonist class is $532.3197 per unit across 12 NDCs.
Which manufacturers make Glucose-dependent Insulinotropic Polypeptide Receptor Agonist drugs?
1 manufacturer makes drugs in the Glucose-dependent Insulinotropic Polypeptide Receptor Agonist class. Ranked by number of NDCs, the largest are Eli Lilly and Company (12).
How has Glucose-dependent Insulinotropic Polypeptide Receptor Agonist pricing changed recently?
Over the past 7 days, 12 NDCs in this class rose and 0 fell, with a class-wide average change of +0.0%.